Comprehensive Geriatric Assessment - Can it Improve Quality of Life

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01925105

Enrollment

220

Registered

2013-08-19

Start date

2013-08-31

Completion date

2016-04-30

Last updated

2015-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life

Keywords

Polypharmacy

Brief summary

Like most developed countries the population of Sweden is getting older and consequently the number of individuals with chronic diseases will be an increasing challenge for its healthcare system. To improve care of the frail elderly, wards with a coordinated multidisciplinary team and multidisciplinary mobile teams were established several years ago. Treatment and follow up is planned in accordance to the patients' medical, psychological and functional capabilities (Comprehensive Geriatric Assessment = CGA). There are to our knowledge only few studies concerning CGA applicable to Swedish conditions. We plan to conduct a Swedish study that evaluates if care and treatment with a modified CGA-model in an outpatient setting can improve quality of life for frail older people.

Interventions

OTHERExperimental: Optimization of treatment

Optimization of treatment of diseases and symptoms

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥65 years * Live in own home * Reason to believe that the health condition is not optimal or could be optimized * Meet at least 2/6 of the following criteria: cognitive impairment, general tiredness or dyspnea, have fallen often/afraid to fall, need help with activities of daily living, hospital care ≥3 times within the last 12 months, care problems at home

Exclusion criteria

* Psychosis * Not understand the Swedish language

Design outcomes

Primary

Measure	Time frame
Retained or increased quality of life of at least 20% measured by EQ-5D (EuroQOL) after 1 year from baseline.	1 year from baseline

Secondary

Measure	Time frame
Readmission to hospital	1 year from baseline

Other

Measure	Time frame
The quality of drug treatment	1 year from baseline

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026